Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Malignant Solid Tumours × Clear all

NCT06600022 2025-01-16

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumours

NCT06304818 2024-03-15

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Malignant Solid Tumours